527 results on '"Rochford Rosemary"'
Search Results
2. Clinical and immunological outcomes of HIV-exposed uninfected and HIV-unexposed uninfected children in the first 24 months of life in Western Kenya
3. Decline in EBV-Specific IFN T cell responses in Kenyan infants from a malaria holoendemic region of Kenya
4. Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responses
5. Epstein–Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992–2008
6. Hemoglobinopathies, merozoite surface protein-2 gene polymorphisms, and acquisition of Epstein Barr virus among infants in Western Kenya
7. Suppression of circulating IgD+CD27+ memory B cells in infants living in a malaria-endemic region of Kenya
8. Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study
9. Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children
10. Macrophages drive KSHV B cell latency
11. Prevalence of and risk factors for microscopic and submicroscopic malaria infections in pregnancy: a systematic review and meta-analysis
12. Environmental determinants of Kaposi’s sarcoma-associated herpesvirus (KSHV) transmission in rural Uganda (ENDKU study): Contributions to research on KSHV infection and reactivation in African children; A longitudinal cohort study
13. Challenges and Approaches to Establishing Multi-Pathogen Serosurveillance: Findings from the 2023 Serosurveillance Summit.
14. Mast Cell Activation and KSHV Infection in Kaposi Sarcoma
15. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
16. Burkitt lymphoma
17. Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cure
18. The Role of the Human Virome in Hematologic Malignancies
19. Immune cell phenotype and function patterns across the life course in individuals from rural Uganda
20. Kaposi’s sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda
21. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children
22. Expansion of extrafollicular B and T cell subsets in childhood-onset systemic lupus erythematosus
23. Determinants of Gammaherpesvirus Shedding in Saliva Among Ugandan Children and Their Mothers
24. Risk Factors of SARS-CoV-2 Antibodies in Arapahoe County First Responders - the COVID-19 Arapahoe SErosurveillance Study (CASES) Project
25. Epstein-Barr Virus Type 2 Infects T Cells in Healthy Kenyan Children
26. Hemin treatment drives viral reactivation and plasma cell differentiation of EBV latently infected B cells
27. Plasmodium falciparum Malaria Is Associated With Increased Kaposi Sarcoma–Associated Herpesvirus (KSHV) Seropositivity and Higher KSHV Antibody Breadth and Magnitude: Results of a Case-Control Study From Rural Uganda
28. Effects of Maternal HIV Infection on Early Kaposi Sarcoma-Associated Herpesvirus Seroconversion in a Kenyan Mother-Infant Cohort
29. Malaria during pregnancy and transplacental transfer of Kaposi sarcoma-associated herpesvirus (KSHV) antibodies: a cohort study of Kenyan mother and child pairs
30. Plasmodium falciparum Malaria Is Associated With Increased Kaposi Sarcoma–Associated Herpesvirus (KSHV) Seropositivity and Higher KSHV Antibody Breadth and Magnitude: Results of a Case-Control Study From Rural Uganda.
31. Effect of Malaria Infection on Epstein-Barr Virus Persistence in Kenyan Children.
32. Infant feeding and treatment practices could lead to enhanced transmission of Kaposi's sarcoma-associated herpesvirus (KSHV) and other orally shed infections via saliva, in rural south-western Uganda.
33. The Role of the Human Virome in Hematologic Malignancies
34. Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
35. Burkitt’s Lymphoma
36. Clinical and Immunological Outcomes of HIV-Exposed Uninfected and HIV-Unexposed Uninfected Children in the First 24 Months of Life in Western Kenya
37. Comparison of Epstein–Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3–89 years from Uganda
38. Evidence for Aerosol Transfer of SARS-CoV-2–Specific Humoral Immunity
39. Viral-associated malignancies in Africa: are viruses ‘infectious traces’ or ‘dominant drivers’?
40. Epstein-Barr virus infection of infants: implications of early age of infection on viral control and risk for Burkitt lymphoma
41. Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection
42. Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children
43. Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants
44. The burden of Burkitt lymphoma in Africa
45. Supplemental legend from Mast Cell Activation and KSHV Infection in Kaposi Sarcoma
46. Table S1 from Mast Cell Activation and KSHV Infection in Kaposi Sarcoma
47. Figure S1 from Mast Cell Activation and KSHV Infection in Kaposi Sarcoma
48. Development of an ectopic huLiver model for Plasmodium liver stage infection
49. Comparison of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda
50. Editorial overview: Special section on immune responses to chronic infections
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.